Aptose Biosciences Inc. (TSX: APS)
0.900
+0.010 (1.12%)
Jul 22, 2024, 9:41 AM EDT
Aptose Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Cash & Equivalents | 7.35 | 9.25 | 36.97 | 39.11 | 117.39 | 79.84 | Upgrade
|
Short-Term Investments | 1.98 | - | 9.99 | 40.01 | 5 | 17.76 | Upgrade
|
Cash & Short-Term Investments | 9.33 | 9.25 | 46.96 | 79.13 | 122.39 | 97.6 | Upgrade
|
Cash Growth | -73.89% | -80.30% | -40.65% | -35.35% | 25.40% | 520.12% | Upgrade
|
Prepaid Expenses | 1.82 | 2.04 | 2.3 | 2.48 | 2.55 | 1.03 | Upgrade
|
Other Current Assets | 0.67 | 0.6 | 0.26 | 0.13 | 0.13 | 0.14 | Upgrade
|
Total Current Assets | 11.82 | 11.89 | 49.52 | 81.74 | 125.08 | 98.77 | Upgrade
|
Gross Property, Plant & Equipment | - | 3.7 | 3.82 | 2.75 | 2.53 | 2.44 | Upgrade
|
Accumulated Depreciation | - | -2.61 | -2.31 | -1.96 | -1.39 | -0.82 | Upgrade
|
Net Property, Plant & Equipment | 0.98 | 1.1 | 1.51 | 0.79 | 1.14 | 1.62 | Upgrade
|
Other Intangible Assets | - | - | - | - | 0.05 | 0.09 | Upgrade
|
Total Assets | 12.8 | 12.99 | 51.03 | 82.53 | 126.26 | 100.48 | Upgrade
|
Accounts Payable | 2.42 | 6.05 | 6.33 | 1.7 | 2.17 | 1.96 | Upgrade
|
Accrued Expenses | 9.32 | 8.83 | 5.66 | 6.02 | 4.1 | 3.06 | Upgrade
|
Current Portion of Leases | 0.4 | 0.39 | 0.3 | 0.46 | 0.54 | 0.52 | Upgrade
|
Total Current Liabilities | 12.14 | 15.27 | 12.28 | 8.17 | 6.81 | 5.54 | Upgrade
|
Long-Term Leases | 0.52 | 0.62 | 1 | 0.12 | 0.54 | 1.01 | Upgrade
|
Total Liabilities | 12.66 | 15.89 | 13.29 | 8.29 | 7.35 | 6.55 | Upgrade
|
Common Stock | 450.49 | 444.81 | 437.52 | 437.39 | 429.52 | 365.49 | Upgrade
|
Additional Paid-In Capital | 79.15 | 72.15 | 68.87 | 63.67 | 50.86 | 34.65 | Upgrade
|
Retained Earnings | -525.18 | -515.54 | -464.33 | -422.51 | -357.15 | -301.92 | Upgrade
|
Comprensive Income & Other | -4.32 | -4.32 | -4.32 | -4.32 | -4.32 | -4.3 | Upgrade
|
Shareholders' Equity | 0.14 | -2.9 | 37.74 | 74.24 | 118.92 | 93.93 | Upgrade
|
Total Liabilities & Equity | 12.8 | 12.99 | 51.03 | 82.53 | 126.26 | 100.48 | Upgrade
|
Total Debt | 0.92 | 1.02 | 1.3 | 0.57 | 1.07 | 1.53 | Upgrade
|
Net Cash (Debt) | 8.41 | 8.24 | 45.66 | 78.55 | 121.32 | 96.07 | Upgrade
|
Net Cash Growth | -75.62% | -81.96% | -41.88% | -35.25% | 26.28% | 510.38% | Upgrade
|
Net Cash Per Share | 0.99 | 1.22 | 7.42 | 13.23 | 22.24 | 28.73 | Upgrade
|
Filing Date Shares Outstanding | 16.31 | 15.72 | 6.2 | 6.15 | 5.93 | 5.08 | Upgrade
|
Total Common Shares Outstanding | 15.72 | 7.94 | 6.16 | 6.15 | 5.93 | 5.07 | Upgrade
|
Working Capital | -0.32 | -3.38 | 37.24 | 73.56 | 118.26 | 93.23 | Upgrade
|
Book Value Per Share | 0.01 | -0.37 | 6.13 | 12.08 | 20.07 | 18.51 | Upgrade
|
Tangible Book Value | 0.14 | -2.9 | 37.74 | 74.24 | 118.87 | 93.83 | Upgrade
|
Tangible Book Value Per Share | 0.01 | -0.37 | 6.13 | 12.08 | 20.06 | 18.49 | Upgrade
|
Machinery | - | 0.37 | 0.54 | 0.71 | 0.5 | 0.42 | Upgrade
|
Source: S&P Capital IQ. Standard template.